All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.
During the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the MDS Hub was pleased to speak to Nil Albiol, Hospital de la Santa Creu i Sant Pau, Barcelona, ES. We asked, Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?
Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?
In this video, Albiol discusses the initial exclusion of transplanted patients from COVID vaccine trials due to the risk of immune-mediated complications. Albiol then comments on the study performed at his center and two other recently published studies, which did not find these side effects in transplanted patients. Finally, Albiol compares the overall results in transplanted patients to the general population.
COVID-19 vaccination for hematopoietic stem cell transplant patients
The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been...
Early Italian experience of COVID-19 in patients with MDS
Infection is a common cause of death in patients with myelodysplastic syndromes (MDS), and during the early stages of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak...
Subscribe to get the best content related to MDS delivered to your inbox